Meeting Overview - The second extraordinary general meeting of shareholders for 2025 was scheduled for September 19, 2025, with prior notification published on September 4, 2025 [4][10] - The meeting was held at the conference room on the 37th floor of Two Rivers International Building, Chengdu [6] Attendance and Voting - A total of 81 shareholders attended the meeting, representing 65,448,492 shares, which is 34.9480% of the total voting shares [11] - The voting was conducted through a combination of on-site and online methods, with 8 shareholders voting on-site and 73 voting online [11][12] Resolutions Passed - The meeting approved the election of non-independent directors: Fu Lihua, Huang Lingyi, and Yao Yan, each serving a term of three years [13][15][21] - The voting results for Fu Lihua showed 64,411,311 votes in favor, accounting for 98.4153% of the valid votes [13] - The meeting also approved the election of independent directors: He Deming, Chen Yan, and Wang Guangying, each also serving a term of three years [22][23] Legal Compliance - The meeting was witnessed by lawyers from Beijing Zhide Law Firm, who confirmed that the meeting's procedures complied with relevant laws and regulations [24]
西藏易明西雅医药科技股份有限公司2025年第二次临时股东会决议公告